AllianceBernstein’s Mirati Therapeutics, Inc. Common Stock MRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q1 | – | Sell |
-738,486
| Closed | -$43.4M | – | 3216 |
|
|
2023
Q4 | $43.4M | Buy |
738,486
+618,858
| +517% | +$34.8M | 0.02% | 629 |
|
|
2023
Q3 | $5.21M | Sell |
119,628
-19,873
| -14% | -$710K | ﹤0.01% | 1401 |
|
|
2023
Q2 | $5.04M | Buy |
139,501
+67,858
| +95% | +$2.8M | ﹤0.01% | 1421 |
|
|
2023
Q1 | $2.66M | Buy |
71,643
+40,275
| +128% | +$1.81M | ﹤0.01% | 1709 |
|
|
2022
Q4 | $1.42M | Sell |
31,368
-13
| -0% | -$841 | ﹤0.01% | 2105 |
|
|
2022
Q3 | $2.19M | Sell |
31,381
-6,219
| -17% | -$460K | ﹤0.01% | 1830 |
|
|
2022
Q2 | $2.52M | Buy |
37,600
+2,006
| +6% | +$128K | ﹤0.01% | 1798 |
|
|
2022
Q1 | $2.93M | Sell |
35,594
-20,651
| -37% | -$2.11M | ﹤0.01% | 1867 |
|
|
2021
Q4 | $8.25M | Buy |
56,245
+8,496
| +18% | +$1.32M | ﹤0.01% | 1354 |
|
|
2021
Q3 | $8.45M | Buy |
47,749
+8,808
| +23% | +$1.42M | ﹤0.01% | 1329 |
|
|
2021
Q2 | $6.29M | Sell |
38,941
-39,357
| -50% | -$6.32M | ﹤0.01% | 1484 |
|
|
2021
Q1 | $13.4M | Sell |
78,298
-400
| -0.5% | -$79.2K | 0.01% | 1070 |
|
|
2020
Q4 | $17.3M | Buy |
78,698
+4,767
| +6% | +$1.03M | 0.01% | 909 |
|
|
2020
Q3 | $12.3M | Sell |
73,931
-7,992
| -10% | -$1.09M | 0.01% | 963 |
|
|
2020
Q2 | $9.35M | Buy |
81,923
+20,500
| +33% | +$1.99M | 0.01% | 1031 |
|
|
2020
Q1 | $4.72M | Buy |
61,423
+2,300
| +4% | +$206K | ﹤0.01% | 1213 |
|
|
2019
Q4 | $7.62M | Buy |
59,123
+1,000
| +2% | +$96.5K | ﹤0.01% | 1199 |
|
|
2019
Q3 | $4.53M | Hold |
58,123
| – | – | ﹤0.01% | 1446 |
|
|
2019
Q2 | $5.99M | Buy |
58,123
+22,834
| +65% | +$1.78M | ﹤0.01% | 1308 |
|
|
2019
Q1 | $2.59M | Sell |
35,289
-69,611
| -66% | -$4.74M | ﹤0.01% | 1758 |
|
|
2018
Q4 | $4.45M | Buy |
104,900
+75,000
| +251% | +$2.99M | ﹤0.01% | 1355 |
|
|
2018
Q3 | $1.41M | Buy |
29,900
+500
| +2% | +$27.8K | ﹤0.01% | 2162 |
|
|
2018
Q2 | $1.45M | Buy |
+29,400
| New | +$1.11M | ﹤0.01% | 2128 |
|
|
2017
Q2 | – | Sell |
-21,300
| Closed | -$111K | – | 3190 |
|
|
2017
Q1 | $111K | Sell |
21,300
-1,600
| -7% | -$8.77K | ﹤0.01% | 2934 |
|
|
2016
Q4 | $109K | Hold |
22,900
| – | – | ﹤0.01% | 2966 |
|
|
2016
Q3 | $151K | Hold |
22,900
| – | – | ﹤0.01% | 2896 |
|
|
2016
Q2 | $125K | Buy |
+22,900
| New | +$365K | ﹤0.01% | 2884 |
|
|
2016
Q1 | – | Sell |
-7,400
| Closed | -$234K | – | 2937 |
|
|
2015
Q4 | $234K | Hold |
7,400
| – | – | ﹤0.01% | 2697 |
|
|
2015
Q3 | $255K | Buy |
+7,400
| New | +$224K | ﹤0.01% | 2708 |
|
|
2015
Q2 | – | Sell |
-1,500
| Closed | -$44K | – | 3308 |
|
|
2015
Q1 | $44K | Buy |
1,500
+1,100
| +275% | +$25.8K | ﹤0.01% | 3153 |
|
|
2014
Q4 | $7K | Hold |
400
| – | – | ﹤0.01% | 3339 |
|
|
2014
Q3 | $7K | Sell |
400
-400
| -50% | -$7.46K | ﹤0.01% | 3329 |
|
|
2014
Q2 | $16K | Buy |
+800
| New | +$15.4K | ﹤0.01% | 3262 |
|
Other funds holding MRTX
AllianceBernstein's MRTX Position: Q1 2024 in Review
AllianceBernstein sold out of Mirati Therapeutics, Inc. Common Stock (MRTX) in Q1 2024, closing a stake of 738,486 shares — an estimated $43.4M sold.
AllianceBernstein first reported a position in MRTX in Q2 2014 and held it in 33 quarters. The position peaked at $43.4M in Q4 2023. 2 funds tracked by Wall St. Rank hold MRTX as of Q1 2024.
- AllianceBernstein reported no remaining Mirati Therapeutics, Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
- AllianceBernstein sold 738,486 Mirati Therapeutics, Inc. Common Stock shares in Q1 2024, an estimated $43.4M.
- AllianceBernstein first reported a position in Mirati Therapeutics, Inc. Common Stock in Q2 2014 and held it in 33 quarters.
- AllianceBernstein's Mirati Therapeutics, Inc. Common Stock position peaked at $43.4M in Q4 2023.
- 2 funds tracked by Wall St. Rank held Mirati Therapeutics, Inc. Common Stock as of Q1 2024.
Based on AllianceBernstein's 13F filing for Q1 2024, filed 14 May 2024.